title: Radiation doses to patients from enteroclysis.
abstract: The purpose of this study was to determine the patient doses during enteroclysis and compare them with the available bibliographical data. For 14 enteroclysis examinations, the dose-area product (DAP) meter readings, fluoroscopy time, number of radiographs and exposure data were recorded. From these data, the fluoroscopy and radiography contributions to DAP, the entrance surface dose (ESD) and the effective dose (E) for each examination were estimated. The mean DAP was 81 Gy cm(2) and the mean fluoroscopy time was 19.5 min. The fluoroscopy contribution to DAP was 77% and 8.7 films were acquired in each examination on average. The mean ESD and E were estimated to be 428 mGy and 21 mSv, respectively. The mean DAP and fluoroscopy time calculated in this study are quite high when compared with those reported in the literature, suggesting that the examination technique should be reviewed and the ways to reduce patient exposure without compromising the diagnostic quality should be acquired.
authors.affiliation: Medical Physics Unit, General Hospital Konstantopoulio-Agia Olga, 3-5 Agias Olgas, Nea Ionia, 142 33 Athens, Greece.
authors.forename: I A
authors.initials: IA
authors.lastname: Tsalafoutas
authors.forename: D A
authors.initials: DA
authors.lastname: Chrysovergis
authors.forename: P N
authors.initials: PN
authors.lastname: Maniatis
authors.forename: A E
authors.initials: AE
authors.lastname: Vassilaki
authors.forename: Ch C
authors.initials: ChC
authors.lastname: Triantopoulou
authors.forename: E N
authors.initials: EN
authors.lastname: Yakoumakis
authors.forename: E D
authors.initials: ED
authors.lastname: Koulentianos
mesh_terms: D000328:Adult; D000368:Aged; D001822:Body Burden; D005260:Female; D005471:Fluoroscopy / Q000706:statistics & numerical data*; D006115:Greece / Q000453:epidemiology; D006801:Humans; D007410:Intestinal Diseases / Q000000981:diagnostic imaging* / Q000453:epidemiology*; D007421:Intestine, Small / Q000000981:diagnostic imaging*; D008297:Male; D008875:Middle Aged; D011829:Radiation Dosage; D011834:Radiation Monitoring / Q000379:methods*; D011835:Radiation Protection / Q000379:methods*; D012062:Relative Biological Effectiveness; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D014965:X-Rays